Daniel S. Goldman, MD, FACC, FHRS

EP Technologies

A Novel, Fully Absorbable Hemostatic Agent (From Purified Plant Starch) With Desiccant Properties for Implantable Device Pocket Management

10/05/2015

Daniel S. Goldman , MD, FACC, FHRS;

Device pocket hematomas continue to be one of the banes of the implanter’s existence. They are a complication of device implants, upgrades, and generator changeouts, with an incidence reported at anywhere from 2-20%.

Device pocket hematomas continue...

10/05/2015

EP Lab Digest

Feature Story

A Novel, Quick and Easy Non-Invasive Option for Skin Closure After Implantable Cardiac Device Procedures

07/07/2014

Daniel S. Goldman , MD, FACC, FHRS;

Linda C. Moulton , RN, MS, MSN;

Recently, a new “non-invasive” device for skin closure was approved for low-tension surgical wounds.

Recently, a new “non-invasive”...

07/07/2014

EP Lab Digest

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Daniel S. Goldman, MD, FACC, FHRS

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products